- Home
- Software
- north america
- cancer testing
Show results for
Refine by
Cancer Testing Software In North America
12 software items found
by:Navigating Cancer, Inc. based inSeattle, WASHINGTON (USA)
Enable real-time oral adherence and symptom reporting while patients are on treatment. Receive proactive information on side effects and intervene quickly. Empower patients to stay on treatment with medication reminders and digital at-home care ...
Manufactured by:Mammoth Biosciences, Inc. based inBrisbane, CALIFORNIA (USA)
The CRISPR-based detection platform: Our revolutionary method for molecular diagnostics, enabling limitless testing ...
by:CureMetrix, Inc. based inSan Diego, CALIFORNIA (USA)
cmTriage™ from CureMetrix is the first FDA-cleared software in the U.S. intended to provide a notification triage code to the radiologist’s mammography worklist based on the presence of a suspicious region of interest found by the underlying algorithm. This workflow optimization tool enables a radiologist to customize their 2D mammogram or mammography worklist based on cases that may ...
by:CureMetrix, Inc. based inSan Diego, CALIFORNIA (USA)
cmDensity An investigational, artificial intelligence- based triage software that helps radiologists classify density accurately and ...
by:CureMetrix, Inc. based inSan Diego, CALIFORNIA (USA)
cmAngio An investigational AI-based triage software that helps doctors assess a patient’s risk of coronary heart disease ...
by:Koios Medical, Inc. based inChicago, ILLINOIS (USA)
Cancer diagnosis with ultrasound requires great vision. Koios uses artificial intelligence and machine learning to provide clinical decision support (“DS”) for physicians and technologists when using ultrasound to detect and diagnose cancer. The result: Smart Ultrasound™ Research continues to prove that physician performance and patient outcomes improve measurably with a second ...
by:PenRad Technologies, Inc. based inBuffalo, MINNESOTA (USA)
Lung screening presents a number of challenges for diagnostic imaging centers with Low Dose Computed Tomography (LDCT). Patients must be screened for eligibility requirements, and participating centers are required to upload pertinent exam information to a lung cancer screening registry in order to qualify for ...
by:PierianDx based inCreve Coeur, MISSOURI (USA)
Clinical Genomics Workspace helps you provide accurate, timely, and actionable results for patients. Developed initially by one of the first medical institutions to launch next generation sequencing tests for cancer and complex inherited diseases, Clinical Genomics Workspace provides a streamlined and clinically integrated software for the analysis, reporting, ...
by:SOPHiA Genetics based inBoston, MASSACHUSETTS (USA)
Confidently assess genetic variants predisposing to cancer. Hereditary causes account for ∼10% of cancer cases, and an estimated 20% of cancer patients have a family history of cancer.1 Identification of an individual with a suspected hereditable cancer can lead to additional examinations and help formulate the most appropriate prevention strategies. Evaluating the predisposition to develop ...
by:SOPHiA Genetics based inBoston, MASSACHUSETTS (USA)
From targeted to comprehensive solutions, Next-Generation-Sequencing (NGS) offers the capacity to simultaneously analyze a select set of genes, regions, and biomarkers based on known involvement across solid tumor such as lung, colon, breast, melanoma, gastric, and ovarian cancers. However, as tests either expand or become more specialized, molecular pathologists ...
Manufactured by:OTraces Inc. based inSykesville, MARYLAND (USA)
The OTraces technology platform drives multiple business opportunities. The software is embedded into a laboratory information management system (LIMS) wherein all patient and instrument data is stored in secure U.S. based servers. This software is the principal value-add for the company’s instrument systems now being developed for prostate and eventually breast cancer patient monitoring ...
by:PenRad Technologies, Inc. based inBuffalo, MINNESOTA (USA)
PenRad’s PenGen system allows facilities to collect and manage patients’ risk assessments and genetic testing eligibility. System calculates real-time cancer risk scores, and Genetic testing eligibility based on multiple models, for patient and ...